Oxygen-ozone therapy (OOT) is an innovative treatment showing potential for various conditions, including knee osteoarthritis (KOA), a joint disorder causing cartilage degeneration, inflammation, and pain. This review evaluates OOT's effectiveness in treating KOA, focusing on pain relief, joint function, and quality of life.
Materials and Methods
The review synthesizes findings from five randomized controlled trials (RCTs) comparing OOT with standard treatments such as corticosteroids, hyaluronic acid, and placebo, assessing its effects on pain relief, joint function, and quality of life.
Results
OOT significantly reduces pain and improves joint mobility in KOA patients, with some studies reporting longer-lasting effects than corticosteroids. OOT also shows anti-inflammatory benefits by reducing pro-inflammatory cytokines, suggesting a potential to modify disease mechanisms. It is minimally invasive and has fewer side effects compared to traditional treatments.
Conclusions
OOT presents a promising alternative to conventional treatments, offering pain relief, functional improvement, and safety benefits. Despite some limitations, such as treatment variability and lack of long-term follow-up, OOT is a valuable therapeutic option for KOA.
De SireAAgostiniFLippiL, et al.Oxygen-Ozone therapy in the rehabilitation field: state of the art on mechanisms of action, safety and effectiveness in patients with musculoskeletal disorders. Biomolecules2021; 11: 56. PMID: 33652804; PMCID: PMC7996934.
2.
XuWZhaoXSunP, et al.The effect of medical ozone treatment on cartilage chondrocyte autophagy in a rat model of osteoarthritis. Am J Transl Res2020; 12: 5967–5976. PMID: 33042472; PMCID: PMC7540152.
3.
JeyaramanMJeyaramanNRamasubramanianS, et al.Ozone therapy in musculoskeletal medicine: a comprehensive review. Eur J Med Res2024; 29: 98. PMID: 39085932; PMCID: PMC11290204.
4.
GuoWXingYLuoX, et al.Reactive oxygen Species: a crosslink between plant and human eukaryotic cell systems. Int J Mol Sci2023; 24: 13052. PMID: 37685857; PMCID: PMC10487619.
5.
SconzaCDi MatteoBQueirazzaP, et al.Ozone therapy versus hyaluronic acid injections for pain relief in patients with knee osteoarthritis: preliminary findings on molecular and clinical outcomes from a randomized controlled trial. Int J Mol Sci2023; 24: 8788. PMID: 37240135; PMCID: PMC10218112.
6.
SconzaCBraghettoGRespizziS, et al.Ultrasound-guided periradicular oxygen-ozone injections as a treatment option for low back pain associated with sciatica. Int Orthop2021; 45: 1239–1246. Epub 2021 Feb 24. PMID: 33629173.
7.
FarìGManciniRDell’AnnaL, et al.Medial or lateral, that is the question: a retrospective study to compare two injection techniques in the treatment of knee osteoarthritis pain with hyaluronic acid. J Clin Med2024; 13: 1141.
8.
BrittbergMGomollAHCansecoJA, et al.Cartilage repair in the degenerative ageing knee. Acta Orthop2016; 87: 26–38.
9.
FarìGPignatelliGMacchiarolaD, et al.Cartilage damage: clinical approach. Minerva Orthop2022; 73: 20–27.
10.
LaslettLLScheepersLEJMAntonyB, et al.Krill oil for knee osteoarthritis: a randomized clinical trial. JAMA2024; 331: 1997–2006. Erratum in: JAMA. 2024 Sep 26. DOI: 10.1001/jama.2024.20532. PMID: 38776073; PMCID: PMC11112499.
11.
GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the global burden of disease study 2021. Lancet Rheumatol2023; 5: e508–e522. PMID: 37675071; PMCID: PMC10477960.
12.
GiarettaSMagniAMiglioreA, et al.A review of current approaches to pain management in knee osteoarthritis with a focus on Italian clinical landscape. J Clin Med2024; 13: 5176.
13.
FarìGMegnaMScaccoS, et al.Hemp seed oil in association with β-caryophyllene, myrcene and ginger extract as a nutraceutical integration in knee osteoarthritis: a double-blind prospective case-control study. Medicina (B Aires)2023; 59: 91.
14.
BernettiAAgostiniFPaoloniM, et al.Could hyaluronic acid be considered as a senomorphic agent in knee osteoarthritis? A systematic review. Biomedicines2023; 11: 2858. PMID: 37893231; PMCID: PMC10604344.
15.
SconzaCRespizziSVirelliL, et al.Oxygen-Ozone therapy for the treatment of knee osteoarthritis: a systematic review of randomized controlled trials. Arthroscopy2020; 36: 277–286. Epub 2019 Oct 31. PMID: 31679646.
16.
BocciVAZanardiITravagliV. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med2011; 9: 66.
17.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J2021; 372: 71. PMID: 33782057; PMCID: PMC8005924.
18.
OlivoSAMacedoLGGadottiIC, et al.Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther2008; 88: 156–175.
19.
MohsinaSGurushankariBNiranjanR. Assessment of the quality of randomized controlled trials in surgery using Jadad score: where do we stand?J Postgrad Med2022; 68: 207–212.
20.
HigginsJPTAltmanDGGotzschePC, et al.The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. Br Med J2011; 343: d5928.
21.
McGuinnessLAHigginsJPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods2021; 12: 55–61.
22.
AslanSGDe SireAKöylüSU, et al.The efficacy of ultrasonography-guided oxygen-ozone therapy versus corticosteroids in patients with knee osteoarthritis: a multicenter randomized controlled trial. J Back Musculoskelet Rehabil2024; 37: 1455–1466. PMID: 39240624; PMCID: PMC11612948.
23.
Lopes de JesusCCDos SantosFCDe JesusLMOB, et al.Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: a randomized, double-blinded, placebo-controlled study. PLoS One2017; 12: e0179185. Erratum in: PLoS One 2024; 19(11): e0314494. DOI: https://doi.org/10.1371/journal.pone.0314494. PMID: 28738079; PMCID: PMC5524330.
24.
FakhariSPishghahiAPourfathiH, et al.A comparison between low-level Laser therapy and intra-articular ozone injection in knee osteoarthritis treatment: a randomized clinical trial. J Lasers Med Sci2021; 12: 44. PMID: 34733767; PMCID: PMC8558735.
25.
Babaei-GhazaniANajarzadehSMansooriK, et al.The effects of ultrasound-guided corticosteroid injection compared to oxygen-ozone (O2-O3) injection in patients with knee osteoarthritis: a randomized controlled trial. Clin Rheumatol2018; 37: 2517–2527. Epub 2018 May 24. PMID: 29796866.
26.
MonticoneMSconzaCPortogheseI, et al.Cross-cultural adaptation, reliability and validity of the Fremantle knee awareness questionnaire in Italian subjects with painful knee osteoarthritis. Health Qual Life Outcomes2021; 19: 14. PMID: 33827594; PMCID: PMC8025485.
27.
BarbourKEHelmickCGBoringM, et al.Vital signs: prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2013-2015. MMWR Morb Mortal Wkly Rep2017; 66: 246–253. PMID: 28278145; PMCID: PMC5687192.
28.
BernettiAMangoneMVillaniC, et al.Appropriateness of clinical criteria for the use of SYmptomatic slow-acting drug for OsteoArthritis (SYSADOA). A Delphi method consensus initiative among experts in Italy. Eur J Phys Rehabil Med2019; 55: 658–664. Epub 2019 May 15. PMID: 31106560.
29.
TedeschiRGiorgiFDonatiD. Harnessing the power of water: a scoping review of hydrokinesiotherapy as a game-changer in knee osteoarthritis management. J Clin Med2024; 13: 5811. PMID: 39407870; PMCID: PMC11477229.
30.
AllaeysCArnoutNVan OnsemS, et al.Conservative treatment of knee osteoarthritis. Acta Orthop Belg2020; 86: 412–421. PMID: 33581025.
31.
BernettiAAgostiniFAlvitiF, et al.New viscoelastic hydrogel hymovis MO.RE. Single intra-articular injection for the treatment of knee osteoarthritis in sportsmen: safety and efficacy study results. Front Pharmacol2021; 12: 673988. PMID: 34122099; PMCID: PMC8195240.
32.
FrizzieroAGiannottiEOlivaF, et al.Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders. Br Med Bull2013; 105: 169–184. Epub 2012 Jul 4. PMID: 22763153.
33.
Dall'OcaCCengarleMCostanzoA, et al.Current concepts in treatment of early knee osteoarthritis and osteochondral lesions; the role of biological augmentations. Acta Biomed2017; 88: 5–10. PMID: 29083347; PMCID: PMC6357662.
34.
RojhaniSQureshiZChhatreA. Water-Cooled radiofrequency provides pain relief, decreases disability, and improves quality of life in chronic knee osteoarthritis. Am J Phys Med Rehabil2017; 96: e5–e8. PMID: 27196385.
35.
VeroneseNHonvoGBruyèreO, et al.Knee osteoarthritis and adverse health outcomes: an umbrella review of meta-analyses of observational studies. Aging Clin Exp Res2023; 35: 245–252. Epub 2022 Nov 4. PMID: 36331799; PMCID: PMC9895027.
36.
FarìGMegnaMScaccoS, et al.Effects of terpenes on the osteoarthritis cytokine profile by modulation of IL-6: double face versus dark knight?Biology (Basel)2023; 12: 1061. PMID: 37626947; PMCID: PMC10452224.
37.
IaconisiGNGalloNCaforioL, et al.Clinical and biochemical implications of hyaluronic acid in musculoskeletal rehabilitation. A Comprehensive Review. J Pers Med2023; 13: 1647.
38.
TonuttiAGranataVMarrellaV, et al.The role of WNT and IL-1 signaling in osteoarthritis: therapeutic implications for platelet-rich plasma therapy. Front Aging2023; 4: 1201019. PMID: 37362206; PMCID: PMC10285667.
